Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients.
Saved in:
| Title: | Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. |
|---|---|
| Authors: | Martinez, Sydni1 (AUTHOR), Sindu, Devika2 (AUTHOR), Nailor, Michael D.1 (AUTHOR), Cherrier, Lauren1,2 (AUTHOR), Tokman, Sofya2 (AUTHOR), Walia, Rajat2 (AUTHOR), Goodlet, Kellie J.3 (AUTHOR) kgoodlet@midwestern.edu |
| Source: | Transplant Infectious Disease. Jun2024, Vol. 26 Issue 3, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13982273 |
|---|---|
| DOI: | 10.1111/tid.14279 |
